Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 0,5 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 0,5 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 1 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 1 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 2 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 2 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
dailiport hart forðahylki 3 mg
sandoz a/s - tacrolimusum mónohýdrat - hart forðahylki - 3 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
Umoja wa Ulaya -
Kiaisilandi -
EMA (European Medicines Agency)
celsentri
viiv healthcare b.v. - maraviroc - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only ccr5-tropic hiv-1 detectable,.
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
cozaar comp forte filmuhúðuð tafla 100/25 mg
n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 100/25 mg
Aislandi -
Kiaisilandi -
LYFJASTOFNUN (Icelandic Medicines Agency)
cozaar comp filmuhúðuð tafla 50+12,5 mg
n.v. organon* - losartanum kalíum; hydrochlorothiazidum inn - filmuhúðuð tafla - 50+12,5 mg